The Manchester based startup will use the capital for product development and distribution research.
"SmartyPlants began with a simple idea: plant care should be intuitive, not intimidating. People want their plants to thrive, but they often don’t have the tools or information to make that easy. Our technology is designed to help users gain clarity and confidence, so they can enjoy their plants rather than worry about them."
The financing extension brings Nuclera's total Series C funding to $87m and will advance antibody engineering capabilities.
"Since our initial investment, Nuclera has made meaningful progress in expanding the capabilities, adoption, and global reach of the eProtein Discovery platform. The extension of the system into full-format antibody expression, purification, and binding validation represents a significant step forward, particularly as biologics discovery becomes increasingly driven by AI-enabled workflows that require scalable, high-quality datasets. Elevage is proud to continue supporting Nuclera as it evolves into a foundational platform for protein and antibody engineering, helping researchers accelerate discovery timelines and reduce friction across the drug development process."
BGF has backed the water technology provider with new funding to accelerate product development and overseas expansion.
"In 2019, we set out on a mission to become water industry innovators by blending technology and engineering to drive down water loss and protect the environment."